References to the first quarters of 2019 and 2018 represent the fiscal quarters ended December 31, 2018 and 2017, respectively.
The Company’s results for the three-month period ended December 31, 2018 are not necessarily indicative of the results for the entire 2019 fiscal year.
Compensation expense related to the restricted share awards was $1.1 million and $1.1 million for the three-month periods ended December 31, 2018 and 2017, respectively.
Compensation expense related to the non-employee director grants was $0.3 million and $0.3 million for the three-month periods ended December 31, 2018 and 2017, respectively.
Products accounted for under this guidance include the construction and installation of complex test chambers to a buyer’s specifications that provide its customers with the ability to measure and contain magnetic, electromagnetic and acoustic energy.
The Company recorded a provisional charge for the Transition Tax of $3.7 million for the year ended September 30, 2018 and this charge is complete as of December 31, 2018 with minimal changes.
During the first quarter of 2019, we recognized approximately $20 million in revenues that were included in the contract liabilities balance at the adoption date.
We recorded a $5.5 million adjustment to increase retained earnings to reflect the cumulative impact of adopting this standard at the beginning of fiscal year 2019, primarily related to certain long-term contracts our Filtration and Technical Packaging segments have that converted to the cost-to-cost method for revenue recognition.
We will recognize revenue based on each day of providing access (straight-line over the contract term).
The contracts may contain multiple products, which are capable of being distinct as the customer could benefit from each product on its own or together with other readily available resources.
Each product is separately identifiable from the other products in the contract.
Approximately 52% of the segment’s revenues (approximately 19% of consolidated revenues) are accounted for over time as the products do not have alternative use and the Company has an enforceable right to payment for costs incurred plus a reasonable margin or the inventory is owned by the customer.The increase in net sales in the first quarter of 2019 as compared to the first quarter of 2018 was due to a $6.2 million increase in the Filtration segment, a $3.8 million increase in the Test segment and a $0.1 million increase in the USG segment, partially offset by a $0.9 million decrease in the Technical Packaging segment.
Net sales increased $9.1 million, or 5.2%, to $182.6 million in the first quarter of 2019 from $173.5 million in the first quarter of 2018.
EBIT in the first quarter of 2019 was $0.1 million (0.6% of net sales) compared to $1.0 million (4.8% of net sales) in the first quarter of 2018.
EBIT was $25.1 million (13.8% of net sales) for the first quarter of 2019 compared to $15.0 million (8.6% of net sales) for the first quarter of 2018.
In the first quarter of 2019, net sales of $66.2 million were $6.2 million, or 10.3%, higher than the $60.0 million in the first quarter of 2018.
In the first quarter of 2019, net sales of $41.3 million were $3.8 million, or 10.0%, higher than the $37.5 million in the first quarter of 2018.